Establishment of a chronic aspiration pneumonia mouse model using oropharyngeal aspiration of food suspension

Abstract

Background: Aspiration pneumonia (AP) is a prevalent and life-threatening pulmonary disease resulting from repeated aspiration of exogenous materials such as food or gastric contents. However, most existing animal models simulate only acute injury and fail to reproduce the chronic pathological features observed in patients. This study aimed to establish a stable and clinically relevant chronic AP mouse model.

Methods: First, four inhalation techniques including unilateral vagotomy (UV), intranasal inoculation (IN), intratracheal instillation (IT), and oropharyngeal aspiration (OA) were evaluated for model establishment in mice. The optimal method OA was applied to administer normal saline (NS), food suspension (FS), or gastric contents (GC) once weekly. Disease progression was evaluated at 2, 4, and 8 weeks. Lung injury was evaluated by tracer distribution, histopathology, cytokine profiling, transcriptomic analysis, and micro-computed tomography (micro-CT).

Results: OA achieved stable pulmonary delivery. Both FS and GC induced lung injury. However, 8-week FS exposure resulted in more severe and persistent damage, characterized by increased alveolar–capillary barrier permeability and elevated cytokine and chemokine levels. Histology showed FS-specific obstructive bronchiolitis with retained food particles, closely mimicking human aspiration pneumonia. Micro-CT revealed gravity-dependent pulmonary consolidation, most evident in the FS group. Transcriptomic analysis indicated activation of neutrophil extracellular traps (NETs) formation during chronic AP progression.

Conclusions: This OA-based FS model reproduced the key pathological and imaging features of human chronic AP and implicated NETs in the disease progression. It provides a robust platform for mechanistic investigation and therapeutic development.

Keywords

aspiration pneumonia / disease models / lung injury / pneumonia

References

[1] Mandell LA, Niederman MS. Aspiration pneumonia. N Engl J Med. 2019; 380(7): 651-663.

[2] Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003; 124(1): 328-336.

[3] Teramoto S. The current definition, epidemiology, animal models and a novel therapeutic strategy for aspiration pneumonia. Respir Investig. 2022; 60(1): 45-55.

[4] Raghavendran K, Nemzek J, Napolitano LM, Knight PR. Aspiration-induced lung injury. Crit Care Med. 2011; 39(4): 818-826.

[5] Teramoto S. Novel preventive and therapeutic strategy for post-stroke pneumonia. Expert Rev Neurother. 2009; 9(8): 1187-1200.

[6] Teramoto S, Fukuchi Y, Sasaki H, et al. High incidence of aspiration pneumonia in community- and hospital-acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan. J Am Geriatr Soc. 2008; 56(3): 577-579.

[7] Lanspa MJ, Jones BE, Brown SM, Dean NC. Mortality, morbidity, and disease severity of patients with aspiration pneumonia. J Hosp Med. 2013; 8(2): 83-90.

[8] Gupte T, Knack A, Cramer JD. Mortality from aspiration pneumonia: incidence, trends, and risk factors. Dysphagia. 2022; 37(6): 1493-1500.

[9] Makhnevich A. Aspiration pneumonia in older adults. J Hosp Med. 2019; 14(7): 429.

[10] Putot A, Putot S, Manckoundia P. Long-term survival after aspiration pneumonia in older inpatients: a comparative study. J Am Med Dir Assoc. 2023; 24(7): 1088-1091.

[11] Cardasis JJ, MacMahon H, Husain AN. The spectrum of lung disease due to chronic occult aspiration. Ann Am Thorac Soc. 2014; 11(6): 865-873.

[12] Barnes TW, Vassallo R, Tazelaar HD, Hartman TE, Ryu JH. Diffuse bronchiolar disease due to chronic occult aspiration. Mayo Clin Proc. 2006; 81(2): 172-176.

[13] Matsuse T, Oka T, Kida K, Fukuchi Y. Importance of diffuse aspiration bronchiolitis caused by chronic occult aspiration in the elderly. Chest. 1996; 110(5): 1289-1293.

[14] Martín-Martínez A, Sitges-Milà C, Miró J, et al. Assessing the prevalence and the underdiagnosis of aspiration pneumonia among older hospitalized patients with community-acquired pneumonia using an artificial intelligence algorithm. Pneumonia (Nathan). 2025; 17(1): 23.

[15] Son YG, Shin J, Ryu HG. Pneumonitis and pneumonia after aspiration. J Dent Anesth Pain Med. 2017; 17(1): 1-12.

[16] Lindenauer PK, Strait KM, Grady JN, et al. Variation in the diagnosis of aspiration pneumonia and association with hospital pneumonia outcomes. Ann Am Thorac Soc. 2018; 15(5): 562-569.

[17] Hu H, Chen J, Shao Y, et al. Establishment of rat model for aspiration pneumonia and potential mechanisms. Anim Models Exp Med. 2025; 8(6): 1105-1118.

[18] Raghavendran K, Davidson BA, Mullan BA, et al. Acid and particulate-induced aspiration lung injury in mice: Importance of MCP-1. Am J Physiol Lung Cell Mol Physiol. 2005; 289(1): L134-L143.

[19] Tatsushima D, Kurioka T, Mizutari K, et al. Effects of unilateral vagotomy on LPS-induced aspiration pneumonia in mice. Dysphagia. 2023; 38(5): 1353-1362.

[20] Puig F, Herrero R, Guillamat-Prats R, et al. A new experimental model of acid- and endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol. 2016; 311(2): L229-L237.

[21] Teramoto S. Animal models of aspiration pneumonia. In: S Teramoto, K Komiya, eds. Aspiration Pneumonia. Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer Singapore; 2020: 143-151.

[22] Egger C, Cannet C, Gérard C, et al. Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology. PLoS One. 2013; 8(5):e63432.

[23] Watson RL, Lung WY, Bensinger SJ, Belperio JA. Oropharyngeal administration of bleomycin in the murine model of pulmonary fibrosis. J Vis Exp. 2025;(219).

[24] Bergamini G, Perico ME, Di Palma S, et al. Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques. PLoS One. 2021; 16(12):e0260627.

[25] Zhang S, Danchuk SD, Imhof KM, et al. Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury. Stem Cell Res Ther. 2013; 4(1):13.

[26] Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001; 344(9): 665-671.

[27] Simpson AJ, Allen JL, Chatwin M, et al. BTS clinical statement on aspiration pneumonia. Thorax. 2023; 78(Suppl 1): s3-s21.

[28] El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med. 2003; 167(12): 1650-1654.

[29] Downing TE, Sporn TA, Bollinger RR, Davis RD, Parker W, Lin SS. Pulmonary histopathology in an experimental model of chronic aspiration is independent of acidity. Exp Biol Med (Maywood). 2008; 233(10): 1202-1212.

[30] Appel JZ, Lee SM, Hartwig MG, et al. Characterization of the innate immune response to chronic aspiration in a novel rodent model. Respir Res. 2007; 8(1):87.

[31] Nihei M, Okazaki T, Ebihara S, et al. Chronic inflammation, lymphangiogenesis, and effect of an anti-VEGFR therapy in a mouse model and in human patients with aspiration pneumonia. J Pathol. 2015; 235(4): 632-645.

[32] Chang JC, Leung JH, Tang T, et al. In the face of chronic aspiration, prolonged ischemic time exacerbates obliterative bronchiolitis in rat pulmonary allografts. Am J Transplant. 2012; 12(11): 2930-2937.

[33] Foster WM, Walters DM, Longphre M, Macri K, Miller LM. Methodology for the measurement of mucociliary function in the mouse by scintigraphy. J Appl Physiol (1985). 2001; 90(3): 1111-1117.

[34] Southam DS, Dolovich M, O'Byrne PM, Inman MD. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol. 2002; 282(4): L833-L839.

[35] Driscoll KE, Costa DL, Hatch G, et al. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci. 2000; 55(1): 24-35.

[36] Seo Y, Qiu L, Magnen M, et al. Optimizing anesthesia and delivery approaches for dosing into lungs of mice. Am J Physiol Lung Cell Mol Physiol. 2023; 325(2): L262-L269.

[37] Van Hoecke L, Job ER, Saelens X, Roose K. Bronchoalveolar lavage of murine lungs to analyze inflammatory cell infiltration. J Vis Exp. 2017; 123:55398.

[38] Matute-Bello G, Downey G, Moore BB, et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011; 44(5): 725-738.

[39] Mukhopadhyay S, Katzenstein ALA. Pulmonary disease due to aspiration of food and other particulate matter: a clinicopathologic study of 59 cases diagnosed on biopsy or resection specimens. Am J Surg Pathol. 2007; 31(5): 752-759.

[40] Hu X, Yi ES, Ryu JH. Aspiration-related deaths in 57 consecutive patients: autopsy study. PLoS One. 2014; 9(7):e103795.

[41] Chandola S, Bhalla AS, Jana M, Naranje P, Vyas S. Pulmonary aspiration syndromes: an imaging-based review. J Thorac Imaging. 2025; 40(4):e0821.

[42] Ocrospoma S, Restrepo MI. Severe aspiration pneumonia in the elderly. J Intensive Med. 2024; 4(3): 307-317.

[43] Lee AS, Ryu JH. Aspiration pneumonia and related syndromes. Mayo Clin Proc. 2018; 93(6): 752-762.

[44] Komiya K, Ishii H, Umeki K, et al. Computed tomography findings of aspiration pneumonia in 53 patients. Geriatr Gerontol Int. 2013; 13(3): 580-585.

[45] Ural BB, Caron DP, Dogra P, et al. Inhaled particulate accumulation with age impairs immune function and architecture in human lung lymph nodes. Nat Med. 2022; 28(12): 2622-2632.

[46] Jo Y, Kim BY, Lee SM, et al. Particulate matter exposure induces pulmonary TH2 responses and oxidative stress-mediated NRF2 activation in mice. Redox Biol. 2025; 82:103632.

[47] Kim DI, Song MK, Yuk JE, Seo HJ, Lee K. Establishment of an artificial particulate matter-induced lung disease model through analyzing pathological changes and transcriptomic profiles in mice. Sci Rep. 2023; 13(1): 5955.

[48] Han H, Oh EY, Lee JH, Park JW, Park HJ. Effects of particulate matter 10 inhalation on lung tissue RNA expression in a murine model. Tuberc Respir Dis (Seoul). 2021; 84(1): 55-66.

[49] Radermecker C, Detrembleur N, Guiot J, et al. Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. J Exp Med. 2020; 217(12):e20201012.

[50] Narasaraju T, Yang E, Samy RP, et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol. 2011; 179(1): 199-210.

[51] Lefrançais E, Mallavia B, Zhuo H, Calfee CS, Looney MR. Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury. JCI Insight. 2018; 3(3):e98178.

[52] Teramoto S, Matsuse T, Oka T, Ito H, Fukuchi Y, Ouchi Y. Investigation of effects of anesthesia and age on aspiration in mice through LacZ gene transfer by recombinant E1-deleted adenovirus vectors. Am J Respir Crit Care Med. 1998; 158(6): 1914-1919.

[53] Teramoto S, Matsui H, Ohga E, Ishii T, Matsuse T, Ouchi Y. A novel model of aspiration in young and old Guinea-pigs using LacZ gene transduction of adenovirus vector. Br J Anaesth. 1999; 83(2): 296-301.

[54] Kitsios GD, Nguyen VD, Sayed K, et al. The upper and lower respiratory tract microbiome in severe aspiration pneumonia. iScience. 2023; 26(6):106832.

Rights & permissions

2026 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.